Former Neuralink Exec's Startup Advances Organ Preservation Technology

Wired
Wired
45m ago
11 views
Science Corporation pioneers portable, automated organ preservation systems to extend viability and reduce costs in transplantation.
Former Neuralink Exec's Startup Advances Organ Preservation Technology
A What happened
Founded by former Neuralink president Max Hodak, Science Corporation is leveraging its expertise in neural interfaces to build next-generation organ perfusion systems. Current machines like ECMO are costly, cumbersome, and require intensive hospital care. Science's new modular and sensor-integrated system promises automated control, portability, and scalability to preserve organs longer and more affordably. The company has maintained rabbit kidneys for 48 hours and aims to extend preservation times to a month. This breakthrough could reshape organ transplant protocols and patient care by enabling longer transport windows and potential outpatient management.

Key insights

  • 1

    Convergence of Longevity Technologies: Science Corporation's shift from neural interfaces to organ preservation evidences cross-sector innovation driven by shared goals of extending human life.

  • 2

    Automation and Modularity Lower Barriers: Automated, modular perfusion systems reduce reliance on specialized staff and expensive equipment, promising broader accessibility and scalability in organ transplantation.

  • 3

    Potential to Decentralize Critical Care: Portable perfusion devices could revolutionize transplant logistics by enabling longer organ preservation and reducing the need for hospital-bound life support, impacting resource allocation.

Takeaways

Science Corporation's organ preservation advancement unites bioengineering and medical technology to tackle critical transplant challenges, signaling a shift toward more efficient and accessible organ support.

Topics

Technology & Innovation Artificial Intelligence Health & Medicine Medicine